Marvin Edeas - Chair of the French Society (SFA) and International Society of Antioxidants (ISANH) and Founder of the World Mitochondria Society (WMS)
The French Society of Antioxidants (SFA) is chaired by Marvin Edeas. He chairs the ISANH (International Society of Antioxidants in Nutrition & Health) which was founded in the year 1998 by himself. Through the SFA, he encourages exchanges and collaboration between researchers, biologists, public health actors, industrialists and doctors, etc. Marvin Edeas, ISANH and the SFA work to transfer basic research to real-world applications whether clinical, pharmaceutical, nutritional or cosmetic.
Marvin Edeas chairs the worldwide conference Targeting Microbiota and Mitochondria. As former Chair and a founder of the Mitochondria Society, he co-edits the company's publication and is the Chair of its 12-monthly congress. Countless organisations call upon the expertise that Marvin Edeas possesses. His annual congress, Paris Redox, is logically handled by the Chair of the International Society of Antioxidants (ISANH).
Marvin Edeas’ Background
He focused his attention on gastrointestinal disease in Pitié Salpêtrière’s Internal Medicine Department. Marvin Edeas worked as an educator at the Paris 13 Bobigny and Poitiers Universities between the years 2004 and 2013. In the early part of the 1990s, Marvin Edeas worked in Armand Trousseau Hospital in the Pulmonary Diseases Department.
Oysters and Peptides Derived from Hydrolysates Modulate Oxidative Stress - Marvin Edeas
Oyster hydrolyzate has applications in the fields of cosmetology, dietetics and medicine. Marvin Edeas’ developments have found a real application. Thanks to these patents, a start-up was founded to market the new peptide.
Marvin Edeas often works with CNRS, INSERM and Paris Descartes University in the Development, Reproduction, Cancer Department. Since 2016, he has affiliated with the Cochin Institute, Paris Descartes University, as a visiting professor. Marvin Edeas holds clinical studies in nephrology patients and studies how microbiota metabolites effect the mitochondrial activity of these patients. His research and study mainly looks at the effects of Inflammation and Oxidative Stress in chronic diseases.
Back in the year 1997, Marvin Edeas defined the factors that lead to blastogenic plasma in HIV Type 1 cases. Marvin Edeas was involved in the first clinical study on the impact of antiretroviral therapy on lactic acidosis and hyperlactatemia. The latency mechanisms of HIV in patients who are HIV positive, on top of the activation factors, is an area which he spent six years studying at the Antoine Béclère Hospital.